Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Bárbara Meléndez"'
Autor:
Isaura Fernández Pérez, Diana Valverde, Concepción Fiaño Valverde, Jenifer Brea Iglesias, María José Villanueva Silva, Martín Lázaro Quintela, Bárbara Meléndez
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Due to their rarity and heterogeneity and despite the introduction of molecular features in the current WHO classification, clinical criteria such as those from the European Organization for Research and Treatment of Cancer (EORTC) and the R
Externí odkaz:
https://doaj.org/article/46adbcd81f8f43abb2a49a1ce1f44dca
Autor:
Javier S. Castresana, Bárbara Meléndez
Publikováno v:
Cells, Vol 12, Iss 16, p 2063 (2023)
Glioblastoma is the most aggressive intracranial tumor [...]
Externí odkaz:
https://doaj.org/article/0a68b22a29884cae8065963b3b9ac043
Autor:
Virginia López, Juan Ramón Tejedor, Antonella Carella, María G. García, Pablo Santamarina-Ojeda, Raúl F. Pérez, Cristina Mangas, Rocío G. Urdinguio, Aitziber Aranburu, Daniel de la Nava, María D. Corte-Torres, Aurora Astudillo, Manuela Mollejo, Bárbara Meléndez, Agustín F. Fernández, Mario F. Fraga
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumor in adulthood. Epigenetic mechanisms are known to play a key role in GBM although the involvement of histone methyltransferase KMT5B and its mark H4K20me2 has remained
Externí odkaz:
https://doaj.org/article/ec4338a095514184a29503d3b2538b89
Autor:
Javier de la Rosa, Alejandro Urdiciain, Bárbara Meléndez, Juan A Rey, Miguel A Idoate, Javier S Castresana
Publikováno v:
Glioma, Vol 1, Iss 1, Pp 22-26 (2018)
Background: Glioblastoma multiforme (GBM) is the most malignant primary brain tumor. Current treatment against this tumor consists of maximal surgical resection without threatening the patient's life, followed by a treatment with temozolomide, with o
Externí odkaz:
https://doaj.org/article/5c03536fc96e4c8687904ebb087a99a4
Autor:
Javier S. Castresana, Bárbara Meléndez
Publikováno v:
Cells, Vol 10, Iss 6, p 1456 (2021)
Glioblastoma is the most malignant primary brain tumor [...]
Externí odkaz:
https://doaj.org/article/9267a0eb4f6a4fbf93c317be2bdfb265
Autor:
Alejandro Urdiciain, Elena Erausquin, María V. Zelaya, Idoya Zazpe, José L. Lanciego, Bárbara Meléndez, Juan A. Rey, Miguel A. Idoate, Natalia A. Riobo-Del Galdo, Javier S. Castresana
Publikováno v:
Biology, Vol 10, Iss 6, p 467 (2021)
Glioblastoma multiforme, the most common type of malignant brain tumor as well as the most aggressive one, lacks an effective therapy. Glioblastoma presents overexpression of mesenchymal markers Snail, Slug, and N-Cadherin and of the autophagic marke
Externí odkaz:
https://doaj.org/article/bdc0fba0691247a994f9dd392c66f8c4
Publikováno v:
Epigenomes, Vol 2, Iss 1, p 5 (2018)
Glioblastoma is the most common form of glioma, as well as the most aggressive. Patients suffering from this disease have a very poor prognosis. Surgery, radiotherapy, and temozolomide are the only approved treatments nowadays. Panobinostat is a pan-
Externí odkaz:
https://doaj.org/article/678570c32c7a450892e95d2015011c17
Autor:
Raquel Ordóñez, Gabriel Gallo-Oller, Soledad Martínez-Soto, Sheila Legarra, Noémie Pata-Merci, Justine Guegan, Giselle Danglot, Alain Bernheim, Bárbara Meléndez, Juan A Rey, Javier S Castresana
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e113105 (2014)
Neuroblastoma has a very diverse clinical behaviour: from spontaneous regression to a very aggressive malignant progression and resistance to chemotherapy. This heterogeneous clinical behaviour might be due to the existence of Cancer Stem Cells (CSC)
Externí odkaz:
https://doaj.org/article/57d88bd5e3cb4e9fbb770a4e543a0227
Autor:
Claude Van Campenhout, Nicky D'Haene, Sandrine Rorive, Laetitia Lebrun, Bárbara Meléndez, Martin Bizet, Isabelle Salmon, Christine Decaestecker, François Fuks, Barbara Alexiou, Lara Absil
Publikováno v:
Journal of Neuropathology and Experimental Neurology
Journal of neuropathology and experimental neurology, 80 (7
Journal of neuropathology and experimental neurology, 80 (7
Intramedullary astrocytomas (IMAs) consist of a heterogeneous group of rare central nervous system (CNS) tumors associated with variable outcomes. A DNA methylation-based classification approach has recently emerged as a powerful tool to further clas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4256ce34746a2ec6abac164f35b8f900
https://pubmed.ncbi.nlm.nih.gov/34363673
https://pubmed.ncbi.nlm.nih.gov/34363673
Autor:
Bárbara Meléndez, Javier S. Castresana
Publikováno v:
Cells, Vol 10, Iss 1456, p 1456 (2021)
Cells
Cells
Glioblastoma is the most malignant primary brain tumor [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390c778648b51bdce72dbc96edc8150c
https://www.mdpi.com/2073-4409/10/6/1456
https://www.mdpi.com/2073-4409/10/6/1456